Showing results (121-130 of 6,316) with videos related to
Sort By:
Pageof 632
Clinical Ophthalmology (Auckland, N.Z.)|December 31, 2010
Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recoveryBilly R Hammond, Lisa M Renzi, Sohel Sachak, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 31, 2010
Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus cameraPedro Romero-Aroca, Ramon Sagarra-Alamo, Josep Basora-Gallisa, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 31, 2010
Pattern-reversal visual-evoked potential in patients with occult macular dystrophyGen Hanazono, Hisao Ohde, Kei Shinoda, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumabNeeraj Pandey, Ayachit GuruprasadClinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherencePaul F Cook, Robert W Bremer, A J Ayala, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Transient tractional retinal detachment in an eye with retinitis pigmentosaShuichiro Hirahara, Yoshio Hirano, Tsutomu Yasukawa, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogsJordana K Schmier, Edmund C Lau, David W CovertClinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitisRebecca A Kuennen, Reynell Harder Smith, Thomas F Mauger, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Cystoid macular edema secondary to immune recovery uveitis in a man with cytomegalovirus retinitis and AIDSKathir YoganathanClinical Ophthalmology (Auckland, N.Z.)|October 20, 2010
Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degenerationEric Chen, David M Brown, Tien P Wong, et al.Pageof 632